Insider trading

Period: 120 months Stock: AGIO + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

279 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

279 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

279 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

279 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
279 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
279 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

279 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
5 Sep 2018
Alenson Carman Principal Accounting Officer
Sold, plan not stated
$25.90K 312 at 83.00
67.2%
Sold half or more
30 Aug 2018
Bowden Christopher Chief Medical Officer
Sold, plan not stated
$136.05K 1,700 at 80.03
64.8%
Sold half or more
29 Aug 2018
Bowden Christopher Chief Medical Officer
Sold, plan not stated
$24.00K 300 at 80.00
24.5%
24 Aug 2018
Hoerter Steven L. Chief Commercial Officer
Sold, plan not stated
$153.59K 2,050 at 74.92
100%
Sold half or more
6 Aug 2018
Biller Scott Chief Scientific Officer
Sold, plan not stated 3×
$240.33K 3,000 at 80.11
5.0%
25 Jul 2018
Hoerter Steven L. Chief Commercial Officer
Sold, plan not stated
$173.39K 2,050 at 84.58
100%
Sold half or more
10 Jul 2018
Bowden Christopher Chief Medical Officer
Sold, plan not stated 2×
$173.51K 2,000 at 86.76
68.4%
Sold half or more
9 Jul 2018
Alenson Carman Principal Accounting Officer
Sold, plan not stated
$23.10K 272 at 84.94
100%
Sold half or more
5 Jul 2018
Biller Scott Chief Scientific Officer
Sold, plan not stated 2×
$250.50K 3,000 at 83.50
5.0%
22 Jun 2018
Hoerter Steven L. Chief Commercial Officer
Sold, plan not stated
$200.04K 2,050 at 97.58
100%
Sold half or more
14 Jun 2018
Sold, plan not stated 3×
$841.93K 9,000 at 93.55
80.4%
Sold half or more
12 Jun 2018
Bowden Christopher Chief Medical Officer
Sold, plan not stated 2×
$185.79K 2,000 at 92.89
69.4%
Sold half or more
5 Jun 2018
Biller Scott Chief Scientific Officer
Sold, plan not stated 3×
$280.10K 3,000 at 93.37
5.0%
1 Jun 2018
Schenkein David P Chief Executive Officer
Sold, plan not stated 4×
$1.24M 13,000 at 95.35
100%
Sold half or more
30 May 2018
Schenkein David P Chief Executive Officer
Sold, plan not stated
$4.11M 45,626 at 90.07
100%
Sold half or more
23 May 2018
Schenkein David P Chief Executive Officer
Sold, plan not stated 3×
$4.46M 49,374 at 90.40
100%
Sold half or more
23 May 2018
Biller Scott Chief Scientific Officer
Sold, plan not stated
$1.37M 15,177 at 90.00
21.0%
23 May 2018
Hoerter Steven L. Chief Commercial Officer
Sold, plan not stated
$175.81K 2,050 at 85.76
100%
Sold half or more
11 May 2018
Bowden Christopher Chief Medical Officer
Sold, plan not stated 2×
$170.00K 2,000 at 85.00
69.4%
Sold half or more
8 May 2018
Bowden Christopher Chief Medical Officer
Sold, plan not stated
$162.76K 2,000 at 81.38
69.4%
Sold half or more
7 May 2018
Biller Scott Chief Scientific Officer
Sold, plan not stated
$245.43K 3,000 at 81.81
5.0%
1 May 2018
Schenkein David P Chief Executive Officer
Sold, plan not stated 3×
$1.08M 13,000 at 83.04
100%
Sold half or more
23 Apr 2018
Hoerter Steven L. Chief Commercial Officer
Sold, plan not stated
$176.20K 2,050 at 85.95
100%
Sold half or more
12 Apr 2018
Bowden Christopher Chief Medical Officer
Sold, plan not stated 2×
$170.19K 2,000 at 85.10
69.4%
Sold half or more
5 Apr 2018
Biller Scott Chief Scientific Officer
Sold, plan not stated 4×
$225.61K 3,000 at 75.20
5.0%
2 Apr 2018
Schenkein David P Chief Executive Officer
Sold, plan not stated 5×
$1.01M 13,000 at 77.72
100%
Sold half or more
22 Mar 2018
Hoerter Steven L. Chief Commercial Officer
Sold, plan not stated
$173.53K 2,050 at 84.65
100%
Sold half or more
19 Mar 2018
Sold, plan not stated
$557.40K 6,800 at 81.97
75.6%
Sold half or more
16 Mar 2018
Scadden David Director
Bought
$16.69K 200 at 83.44
53.9%
First buy on file
14 Mar 2018
Bowden Christopher Chief Medical Officer
Sold, plan not stated 2×
$164.66K 2,000 at 82.33
69.4%
Sold half or more
5 Mar 2018
Biller Scott Chief Scientific Officer
Sold, plan not stated 4×
$249.23K 3,000 at 83.08
5.4%
1 Mar 2018
Schenkein David P Chief Executive Officer
Sold, plan not stated 2×
$1.05M 13,000 at 81.09
100%
Sold half or more
22 Feb 2018
Hoerter Steven L. Chief Commercial Officer
Sold, plan not stated
$161.19K 2,050 at 78.63
100%
Sold half or more
16 Feb 2018
Bowden Christopher Chief Medical Officer
Sold, plan not stated 2×
$155.31K 2,000 at 77.65
69.4%
Sold half or more
5 Feb 2018
Biller Scott Chief Scientific Officer
Sold, plan not stated 4×
$228.13K 3,000 at 76.04
5.4%
1 Feb 2018
Schenkein David P Chief Executive Officer
Sold, plan not stated 2×
$1.02M 13,000 at 78.75
100%
Sold half or more
1 Feb 2018
Bowden Christopher Chief Medical Officer
Sold, plan not stated 2×
$157.50K 2,000 at 78.75
69.4%
Sold half or more
26 Jan 2018
Schenkein David P Chief Executive Officer
Sold, plan not stated 3×
$1.91M 23,572 at 81.09
100%
Sold half or more
24 Jan 2018
Schenkein David P Chief Executive Officer
Sold, plan not stated 2×
$1.08M 13,553 at 80.01
100%
Sold half or more
23 Jan 2018
CELGENE CORP /DE/ 10% owner
Bought
$57.03M 851,154 at 67.00
163%
First buy on file
23 Jan 2018
Schenkein David P Chief Executive Officer
Sold, plan not stated
$2.63M 32,875 at 80.01
100%
Sold half or more
23 Jan 2018
Hoerter Steven L. Chief Commercial Officer
Sold, plan not stated
$1.87M 25,000 at 74.83
100%
Sold half or more
16 Jan 2018
Schenkein David P Chief Executive Officer
Sold, plan not stated 4×
$3.88M 53,000 at 73.16
100%
Sold half or more
12 Jan 2018
Alenson Carman Principal Accounting Officer
Sold, plan not stated
$161.25K 2,150 at 75.00
100%
Sold half or more
10 Jan 2018
Biller Scott Chief Scientific Officer
Sold, plan not stated
$195.00K 3,000 at 65.00
5.4%
7 Dec 2017
Sold, plan not stated 2×
$55.33K 919 at 60.21
1.1%
7 Dec 2017
Cantley Lewis Clayton Jr. Director · indirect
Sold, plan not stated 2×
$55.33K 919 at 60.21
1.1%
6 Dec 2017
Cantley Lewis Clayton Jr. Director · indirect
Sold, plan not stated 3×
$58.60K 1,000 at 58.60
1.2%
6 Dec 2017
Sold, plan not stated 3×
$58.60K 1,000 at 58.60
1.2%
1 Dec 2017
Schenkein David P Chief Executive Officer
Sold, plan not stated 2×
$369.29K 6,000 at 61.55
100%
Sold half or more
Showing 151–200 of 279. ← Newer Page 4 of 6 Older →